Русский
Nederlandse taal
Deutsch
Francés
한국어
Português
Español
日本語
ไทย
Derm Cross Linked Hyaluronic Acid
Ingredient: 22mg/ml hyaluronic acid
Specification: 1ml, 2ml, 3ml, 5ml, 10ml, 20ml, 50ml
Package: Syringe
Recommended use: 1-3 pcs, 12 months apart
Application Area:
Cheek apple muscle, neck lines, forehead lines, eyes, lips, back of hand, nasolabial groove, mouth pouch, puppet lines etc
Product Introduction：
Our crosslinked HA range includes Structural solutions (D24+/S24+) for dermal filler ,Micro-crosslinked D12 with 150-200μm particle size for superficial rhytids
Chromatic HD20 containing tocopherol β-carotene for lip revitalization. Independent rheological testing confirms 22% lower G' modulus versus. Restylane Lyft, enabling smoother tissue integration and reduced Tyndall effect incidence.
Product Display：
Product Details:
Type | Derm |
Ingredient | Cross Linked Hyaluronic Acid Dermal Filler |
Specification | 1ml, 2ml, 3ml, 5ml, 10ml, 20ml, 50ml |
Cross Link | BDDE chemical cross link |
Texture | Gel |
Elasticity | 250 Pa-400 Pa |
Viscosity | 40Pa-100Pa |
Mean particle size | 200μm-400μm |
Effective content | 20mg/mL |
Cross linker residue | No,or≤0.5ug/g |
Protein residue | ≤20μg/g |
Endotoxin content | <0.5EU/mL |
Swelling degree | 30-50 |
Extruding force | 18N-25N |
Application area | Cheek apple muscle, neck lines, forehead lines, eyes, lips, back of hand, nasolabial groove, mouth pouch, puppet lines etc |
Package | Syringe |
Stoarge | Room temperature (1-25ºC), cool and dry place |
Recommended | 1-3 pcs (vary with each individual |
Recommended interval | 12 month |
Product Package:
Product Advantage:
Customer Feedback:
Raw Material Advantages：
1.CLHA's modified rheological profile enables simultaneous correction of multiple facial layers with single-product injection.
2.Cross-linked formulations maintain clinical performance across broad temperature ranges (-20°C to 60°C).
3.The material demonstrates improved resistance to γ-radiation sterilization compared to non-cross-linked HA.
Development Process:
Company Introduction:
Jinan Grandwill combines technical expertise with stringent quality assurance. With 4 utility patents and 7 inventions secured since 2014, our 5,000-sqm facility produces sterile medical powders, applicators, and implantables. Equipped with microbial labs and ISO 13485-certified processes, we guarantee BDDE-free formulations and thermal stability across all products, meeting global regulatory benchmarks.
Factory Equipment:
